HIV Diagnostic Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

HIV Diagnostic Market to 2027 - Global Analysis and Forecasts By Product (Consumables, Instruments, Software and Services); Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification, , ); End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, and Other End User.)

Report Code: TIPRE00004162 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
HIV or Human Immunodeficiency Virus attacks the cells in the immune system that destroys the white blood cell in the immune system called a T-helper cells, and make copies of itself inside these cells.

MARKET DYNAMICS
The HIV Diagnostic market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of HIV/AIDS worldwide, increasing number of transfusions & blood donations that cause infections, advancements of simple rapid assays with visual testing, and growing awareness about HIV/AIDS. Nevertheless, high cost of Nucleic Acid Testing and lack of mandates for NAT is expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global HIV Diagnostic Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of HIV Diagnostic market with detailed market segmentation by product, test type, end user and geography. The global HIV Diagnostic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading HIV Diagnostic/lung stent market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global HIV Diagnostic market is segmented on the basis of Product, Test Type and End User. Based on Product the market is segmented into Consumables, Instruments, Software and Services. Consumable, by Product is further sub-segmented into Assays, Kits and Reagents and Other Consumables. Based on Test Type Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, and Tests for Viral Identification. Antibody, By Test Type is further sub-segmented into HIV-1 Screening Tests and HIV-1 Antibody Confirmatory Tests. Based on End User the market is segmented into Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, and Other End User.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global HIV Diagnostic market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The HIV Diagnostic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting HIV Diagnostic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the HIV Diagnostic market in these regions.

MARKET PLAYERS
The reports cover key developments in the HIV Diagnostic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from HIV Diagnostic market are anticipated to lucrative growth opportunities in the future with the rising demand for HIV Diagnostic market in the global market. Below mentioned is the list of few companies engaged in the HIV Diagnostic market.

The report also includes the profiles of HIV Diagnostic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott Healthcare
  • Alere Inc
  • Brsitol-Myers Squibb
  • Abbvie Inc
  • Gilead Sciences
  • Janssen Therapeutics
  • BD Biosciences
  • Beckman Coulter
  • PointCare Technologies Inc
  • Roche Diagnostics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 HIV Diagnostic Market - By Product
1.3.2 HIV Diagnostic Market - By Test Type
1.3.3 HIV Diagnostic Market - By End User
1.3.4 HIV Diagnostic Market - By
1.3.5 HIV Diagnostic Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HIV DIAGNOSTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HIV DIAGNOSTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HIV DIAGNOSTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. HIV DIAGNOSTIC - GLOBAL MARKET OVERVIEW
6.2. HIV DIAGNOSTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HIV DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis
7.3.3. Assays Market
7.3.3.1. Overview
7.3.3.2. Assays Market Forecast and Analysis
7.3.4. Kits and Reagents and Other Consumables Market
7.3.4.1. Overview
7.3.4.2. Kits and Reagents and Other Consumables Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
7.5. SOFTWARE AND SERVICES
7.5.1. Overview
7.5.2. Software and Services Market Forecast and Analysis
8. HIV DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANTIBODY TESTS
8.3.1. Overview
8.3.2. Antibody Tests Market Forecast and Analysis
8.3.3. into HIV-1 Screening Tests and HIV-1 Antibody Confirmatory Tests Market
8.3.3.1. Overview
8.3.3.2. into HIV-1 Screening Tests and HIV-1 Antibody Confirmatory Tests Market Forecast and Analysis
8.4. VIRAL LOAD TESTS
8.4.1. Overview
8.4.2. Viral Load Tests Market Forecast and Analysis
8.5. CD4 TESTS
8.5.1. Overview
8.5.2. CD4 Tests Market Forecast and Analysis
8.6. TESTS FOR EARLY INFANT DIAGNOSIS
8.6.1. Overview
8.6.2. Tests for Early Infant Diagnosis Market Forecast and Analysis
8.7. TESTS FOR VIRAL IDENTIFICATION
8.7.1. Overview
8.7.2. Tests for Viral Identification Market Forecast and Analysis
8.8.
8.8.1. Overview
8.8.2. Market Forecast and Analysis
8.9.
8.9.1. Overview
8.9.2. Market Forecast and Analysis
9. HIV DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC LABORATORIES, HOSPITALS, BLOOD BANKS, HOME CARE SETTINGS, AND OTHER END USER.
9.3.1. Overview
9.3.2. Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, and Other End User. Market Forecast and Analysis
10. HIV DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 -
10.1. OVERVIEW
10.2. MARKET FORECASTS AND ANALYSIS
10.3.
10.3.1. Overview
10.3.2. Market Forecast and Analysis
11. HIV DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America HIV Diagnostic Market Overview
11.1.2 North America HIV Diagnostic Market Forecasts and Analysis
11.1.3 North America HIV Diagnostic Market Forecasts and Analysis - By Product
11.1.4 North America HIV Diagnostic Market Forecasts and Analysis - By Test Type
11.1.5 North America HIV Diagnostic Market Forecasts and Analysis - By End User
11.1.6 North America HIV Diagnostic Market Forecasts and Analysis - By
11.1.7 North America HIV Diagnostic Market Forecasts and Analysis - By Countries
11.1.7.1 United States HIV Diagnostic Market
11.1.7.1.1 United States HIV Diagnostic Market by Product
11.1.7.1.2 United States HIV Diagnostic Market by Test Type
11.1.7.1.3 United States HIV Diagnostic Market by End User
11.1.7.1.4 United States HIV Diagnostic Market by
11.1.7.2 Canada HIV Diagnostic Market
11.1.7.2.1 Canada HIV Diagnostic Market by Product
11.1.7.2.2 Canada HIV Diagnostic Market by Test Type
11.1.7.2.3 Canada HIV Diagnostic Market by End User
11.1.7.2.4 Canada HIV Diagnostic Market by
11.1.7.3 Mexico HIV Diagnostic Market
11.1.7.3.1 Mexico HIV Diagnostic Market by Product
11.1.7.3.2 Mexico HIV Diagnostic Market by Test Type
11.1.7.3.3 Mexico HIV Diagnostic Market by End User
11.1.7.3.4 Mexico HIV Diagnostic Market by
11.1.7.4 US HIV Diagnostic Market
11.1.7.4.1 US HIV Diagnostic Market by Product
11.1.7.4.2 US HIV Diagnostic Market by Test Type
11.1.7.4.3 US HIV Diagnostic Market by End User
11.1.7.4.4 US HIV Diagnostic Market by
11.2. EUROPE
11.2.1 Europe HIV Diagnostic Market Overview
11.2.2 Europe HIV Diagnostic Market Forecasts and Analysis
11.2.3 Europe HIV Diagnostic Market Forecasts and Analysis - By Product
11.2.4 Europe HIV Diagnostic Market Forecasts and Analysis - By Test Type
11.2.5 Europe HIV Diagnostic Market Forecasts and Analysis - By End User
11.2.6 Europe HIV Diagnostic Market Forecasts and Analysis - By
11.2.7 Europe HIV Diagnostic Market Forecasts and Analysis - By Countries
11.2.7.1 Germany HIV Diagnostic Market
11.2.7.1.1 Germany HIV Diagnostic Market by Product
11.2.7.1.2 Germany HIV Diagnostic Market by Test Type
11.2.7.1.3 Germany HIV Diagnostic Market by End User
11.2.7.1.4 Germany HIV Diagnostic Market by
11.2.7.2 France HIV Diagnostic Market
11.2.7.2.1 France HIV Diagnostic Market by Product
11.2.7.2.2 France HIV Diagnostic Market by Test Type
11.2.7.2.3 France HIV Diagnostic Market by End User
11.2.7.2.4 France HIV Diagnostic Market by
11.2.7.3 Italy HIV Diagnostic Market
11.2.7.3.1 Italy HIV Diagnostic Market by Product
11.2.7.3.2 Italy HIV Diagnostic Market by Test Type
11.2.7.3.3 Italy HIV Diagnostic Market by End User
11.2.7.3.4 Italy HIV Diagnostic Market by
11.2.7.4 Spain HIV Diagnostic Market
11.2.7.4.1 Spain HIV Diagnostic Market by Product
11.2.7.4.2 Spain HIV Diagnostic Market by Test Type
11.2.7.4.3 Spain HIV Diagnostic Market by End User
11.2.7.4.4 Spain HIV Diagnostic Market by
11.2.7.5 United Kingdom HIV Diagnostic Market
11.2.7.5.1 United Kingdom HIV Diagnostic Market by Product
11.2.7.5.2 United Kingdom HIV Diagnostic Market by Test Type
11.2.7.5.3 United Kingdom HIV Diagnostic Market by End User
11.2.7.5.4 United Kingdom HIV Diagnostic Market by
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific HIV Diagnostic Market Overview
11.3.2 Asia-Pacific HIV Diagnostic Market Forecasts and Analysis
11.3.3 Asia-Pacific HIV Diagnostic Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific HIV Diagnostic Market Forecasts and Analysis - By Test Type
11.3.5 Asia-Pacific HIV Diagnostic Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific HIV Diagnostic Market Forecasts and Analysis - By
11.3.7 Asia-Pacific HIV Diagnostic Market Forecasts and Analysis - By Countries
11.3.7.1 Australia HIV Diagnostic Market
11.3.7.1.1 Australia HIV Diagnostic Market by Product
11.3.7.1.2 Australia HIV Diagnostic Market by Test Type
11.3.7.1.3 Australia HIV Diagnostic Market by End User
11.3.7.1.4 Australia HIV Diagnostic Market by
11.3.7.2 China HIV Diagnostic Market
11.3.7.2.1 China HIV Diagnostic Market by Product
11.3.7.2.2 China HIV Diagnostic Market by Test Type
11.3.7.2.3 China HIV Diagnostic Market by End User
11.3.7.2.4 China HIV Diagnostic Market by
11.3.7.3 India HIV Diagnostic Market
11.3.7.3.1 India HIV Diagnostic Market by Product
11.3.7.3.2 India HIV Diagnostic Market by Test Type
11.3.7.3.3 India HIV Diagnostic Market by End User
11.3.7.3.4 India HIV Diagnostic Market by
11.3.7.4 Japan HIV Diagnostic Market
11.3.7.4.1 Japan HIV Diagnostic Market by Product
11.3.7.4.2 Japan HIV Diagnostic Market by Test Type
11.3.7.4.3 Japan HIV Diagnostic Market by End User
11.3.7.4.4 Japan HIV Diagnostic Market by
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa HIV Diagnostic Market Overview
11.4.2 Middle East and Africa HIV Diagnostic Market Forecasts and Analysis
11.4.3 Middle East and Africa HIV Diagnostic Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa HIV Diagnostic Market Forecasts and Analysis - By Test Type
11.4.5 Middle East and Africa HIV Diagnostic Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa HIV Diagnostic Market Forecasts and Analysis - By
11.4.7 Middle East and Africa HIV Diagnostic Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa HIV Diagnostic Market
11.4.7.1.1 South Africa HIV Diagnostic Market by Product
11.4.7.1.2 South Africa HIV Diagnostic Market by Test Type
11.4.7.1.3 South Africa HIV Diagnostic Market by End User
11.4.7.1.4 South Africa HIV Diagnostic Market by
11.4.7.2 Saudi Arabia HIV Diagnostic Market
11.4.7.2.1 Saudi Arabia HIV Diagnostic Market by Product
11.4.7.2.2 Saudi Arabia HIV Diagnostic Market by Test Type
11.4.7.2.3 Saudi Arabia HIV Diagnostic Market by End User
11.4.7.2.4 Saudi Arabia HIV Diagnostic Market by
11.4.7.3 U.A.E HIV Diagnostic Market
11.4.7.3.1 U.A.E HIV Diagnostic Market by Product
11.4.7.3.2 U.A.E HIV Diagnostic Market by Test Type
11.4.7.3.3 U.A.E HIV Diagnostic Market by End User
11.4.7.3.4 U.A.E HIV Diagnostic Market by
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America HIV Diagnostic Market Overview
11.5.2 South and Central America HIV Diagnostic Market Forecasts and Analysis
11.5.3 South and Central America HIV Diagnostic Market Forecasts and Analysis - By Product
11.5.4 South and Central America HIV Diagnostic Market Forecasts and Analysis - By Test Type
11.5.5 South and Central America HIV Diagnostic Market Forecasts and Analysis - By End User
11.5.6 South and Central America HIV Diagnostic Market Forecasts and Analysis - By
11.5.7 South and Central America HIV Diagnostic Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil HIV Diagnostic Market
11.5.7.1.1 Brazil HIV Diagnostic Market by Product
11.5.7.1.2 Brazil HIV Diagnostic Market by Test Type
11.5.7.1.3 Brazil HIV Diagnostic Market by End User
11.5.7.1.4 Brazil HIV Diagnostic Market by
11.5.7.2 Argentina HIV Diagnostic Market
11.5.7.2.1 Argentina HIV Diagnostic Market by Product
11.5.7.2.2 Argentina HIV Diagnostic Market by Test Type
11.5.7.2.3 Argentina HIV Diagnostic Market by End User
11.5.7.2.4 Argentina HIV Diagnostic Market by
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HIV DIAGNOSTIC MARKET, KEY COMPANY PROFILES
13.1. ABBOTT HEALTHCARE
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALERE INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BRSITOL-MYERS SQUIBB
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ABBVIE INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GILEAD SCIENCES
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JANSSEN THERAPEUTICS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BD BIOSCIENCES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BECKMAN COULTER
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. POINTCARE TECHNOLOGIES INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ROCHE DIAGNOSTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- Abbott Healthcare
- Alere Inc
- Brsitol-Myers Squibb
- Abbvie Inc
- Gilead Sciences
- Janssen Therapeutics
- BD Biosciences
- Beckman Coulter
- PointCare Technologies Inc
- Roche Diagnostics
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book